CLARKSBURG, Md.–(BUSINESS WIRE)–For the last 53 years, BrightFocus Foundation, a nonprofit dedicated to Alzheimer’s, macular degeneration, and glaucoma research, has been making an unconventional bet. What happens when you give promising and emerging scientists funding to pursue early‑stage, high‑risk research that could lead to major scientific advances and future competitive grants? According to an impact assessment commissioned by BrightFocus and conducted by the American Institute of Biol
